NCT04670198

Brief Summary

Adolescence is a period of intense physiological, psychological and social change. It can be a challenging period for young people with Type 1 diabetes and is associated with worsening blood sugar control and care disengagement. The investigators have co-designed with young people a psychologically modelled educational programme - Youth Empowerment Skills (YES), which aims to facilitate a positive adaption to living with diabetes while improving knowledge and self-management behaviours. Integrated programme components include social and peer-based learning, immersive simulations, and an outreach youth worker. The aim of this study is to test the feasibility of the YES programme (acceptance, implementability, recruitment and completion), and estimate its efficacy in relation to metabolic and psychosocial outcomes. The investigators will recruit young people with Type 1 diabetes and conduct a feasibility randomised controlled trial (waiting-list design) with integrated process evaluation. Sixty young people will be randomised to either YES intervention or waiting-list control and evaluate outcomes at 6-months; at this point the waiting list participants will be offered the YES intervention with further follow-up at 12 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 17, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
Last Updated

October 6, 2023

Status Verified

September 1, 2023

Enrollment Period

1.8 years

First QC Date

November 17, 2020

Last Update Submit

October 5, 2023

Conditions

Keywords

Diabetes Mellitus, Type 1AdolescentPsychosocial Support Systems

Outcome Measures

Primary Outcomes (1)

  • Glycated haemoglobin (HbA1c)

    HbA1c will be used to measure: 1. the number of participants achieving clinically significant reductions of 5.5mmol/mol or more and mean differences between groups over time 2. the standard deviation (SD) of the mean difference between the intervention and control group in HbA1c at 6 months; for the control group the SD of the mean difference between HbA1c at 12 months and pre-exposure (phase 2) and for the phase 1 intervention group the SD of the mean HbA1c difference between post (6 and 12 months) and pre-exposure.

    Baseline, 6 months, 12 months

Secondary Outcomes (12)

  • Frequency of blood glucose monitoring

    Baseline, 6 months, 12 months

  • Insulin adherence

    Baseline, 6 months, 12 months

  • Self-Management of Diabetes in Adolescence Scale (SMOD-A)

    Baseline, 6 months, 12 months

  • Confidence in Diabetes Self-Care Scale (CDSS)

    Baseline, 6 months, 12 months

  • Diabetes Quality of Life Instrument (DQOL) (adapted for youth)

    Baseline, 6 months, 12 months

  • +7 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The intervention arm will receive the Youth Empowerment Skills (YES) programme.

Behavioral: Youth Empowerment Skills

Waiting-list control

OTHER

The waiting-list control arm will receive usual care for six months before receiving the Youth Empowerment Skills (YES) programme.

Behavioral: Waiting-list control

Interventions

The Youth Empowerment Skills (YES) programme is a novel psychoeducational intervention with simulation-based experiential learning tailored to the needs of young people. It is based on a social-cognitive learning model, and comprises attendance at 3 all-day YES sessions in non-healthcare settings (groups of 10); and then post-programme networking through social media and follow-up events facilitated by the youth worker. Sessions are led by a peer-educator and a health professional

Intervention

Usual care for 6 months, followed by the YES programme.

Waiting-list control

Eligibility Criteria

Age14 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of Type 1 diabetes
  • Sub-optimal glycaemic control (HbA1c 8.5%)
  • No current or planned attendance at other structured education programmes

You may not qualify if:

  • Severe, physical/mental illness
  • Pregnancy
  • Unstable retinopathy
  • Significant learning difficulties

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Guy's and St Thomas' NHS Foundation Trust

London, SE1 9RS, United Kingdom

Location

University Lewisham Hospital

London, SE13 6LH, United Kingdom

Location

Queen Elizabeth Hospital

London, SE18 4QH, United Kingdom

Location

King's College Hospital

London, SE5 9RS, United Kingdom

Location

St George's University Hospital HS Foundation Trust

London, SW17 0QT, United Kingdom

Location

Related Publications (1)

  • Kariyawasam D, Soukup T, Parsons J, Sevdalis N, Baldellou Lopez M, Forde R, Ismail K, Jones M, Ford-Adams M, Yemane N, Pender S, Thomas S, Murrells T, Silverstien A, Forbes A. Protocol for a feasibility study and process evaluation of a psychosocially modelled diabetes education programme for young people with type 1 diabetes: the Youth Empowerment Skills (YES) programme. BMJ Open. 2022 Jun 9;12(6):e062971. doi: 10.1136/bmjopen-2022-062971.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Angus Forbes

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: The study has been designed as a waiting-list randomised controlled trial (RCT). Young people will be randomised to either the phase 1 YES group or the waiting-list control group. The phase 1 YES group will then attend the programme, both groups will be followed-up initially for 6 months, at which point the waiting-list control participants will attend the YES programme in phase 2. Both groups will then be followed-up for a further 6 months.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2020

First Posted

December 17, 2020

Study Start

June 1, 2021

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

October 6, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share

IPD that underlie results in a publication will be shared

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be available at the end of the study.
Access Criteria
Requests made to study researchers

Locations